These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 20585537)
1. Primaquine administration after falciparum malaria treatment in malaria hypoendemic areas with high incidence of falciparum and vivax mixed infection: pros and cons. Wilairatana P; Tangpukdee N; Kano S; Krudsood S Korean J Parasitol; 2010 Jun; 48(2):175-7. PubMed ID: 20585537 [TBL] [Abstract][Full Text] [Related]
2. [Role of primaquine in malaria control and elimination in French-speaking Africa]. Briolant S; Pradines B; Basco LK Bull Soc Pathol Exot; 2017 Aug; 110(3):198-206. PubMed ID: 28417346 [TBL] [Abstract][Full Text] [Related]
3. Supervised versus unsupervised primaquine radical cure for the treatment of falciparum and vivax malaria in Papua, Indonesia: a cluster-randomised, controlled, open-label superiority trial. Poespoprodjo JR; Burdam FH; Candrawati F; Ley B; Meagher N; Kenangalem E; Indrawanti R; Trianty L; Thriemer K; Price DJ; Simpson JA; Price RN Lancet Infect Dis; 2022 Mar; 22(3):367-376. PubMed ID: 34710363 [TBL] [Abstract][Full Text] [Related]
4. Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study. Devine A; Battle KE; Meagher N; Howes RE; Dini S; Gething PW; Simpson JA; Price RN; Lubell Y PLoS Med; 2021 Jun; 18(6):e1003614. PubMed ID: 34061843 [TBL] [Abstract][Full Text] [Related]
5. Relapses contribute significantly to the risk of Plasmodium vivax infection and disease in Papua New Guinean children 1-5 years of age. Betuela I; Rosanas-Urgell A; Kiniboro B; Stanisic DI; Samol L; de Lazzari E; Del Portillo HA; Siba P; Alonso PL; Bassat Q; Mueller I J Infect Dis; 2012 Dec; 206(11):1771-80. PubMed ID: 22966124 [TBL] [Abstract][Full Text] [Related]
6. Plasmodium vivax malaria relapses at a travel medicine centre in Rio de Janeiro, a non-endemic area in Brazil. Pedro RS; Guaraldo L; Campos DP; Costa AP; Daniel-Ribeiro CT; Brasil P Malar J; 2012 Jul; 11():245. PubMed ID: 22839416 [TBL] [Abstract][Full Text] [Related]
7. Radical curative efficacy of five-day regimen of primaquine for treatment of Plasmodium vivax malaria in India. Yadav RS; Ghosh SK J Parasitol; 2002 Oct; 88(5):1042-4. PubMed ID: 12435158 [TBL] [Abstract][Full Text] [Related]
8. Reducing the risk of Plasmodium vivax after falciparum infections in co-endemic areas-a randomized controlled trial (PRIMA). Thriemer K; Degaga TS; Christian M; Alam MS; Ley B; Hossain MS; Kibria MG; Tego TT; Abate DT; Weston S; Karahalios A; Rajasekhar M; Simpson JA; Rumaseb A; Mnjala H; Lee G; Anose RT; Kidane FG; Woyessa A; Baird K; Sutanto I; Hailu A; Price RN Trials; 2022 May; 23(1):416. PubMed ID: 35585641 [TBL] [Abstract][Full Text] [Related]
9. Treatment-seeking behaviour and associated costs for malaria in Papua, Indonesia. Karyana M; Devine A; Kenangalem E; Burdarm L; Poespoprodjo JR; Vemuri R; Anstey NM; Tjitra E; Price RN; Yeung S Malar J; 2016 Nov; 15(1):536. PubMed ID: 27821127 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic assessment of chloroquine-primaquine combined regimen in adult cohort of Plasmodium vivax malaria from a tertiary care hospital in southwestern India. Rishikesh K; Kamath A; Hande MH; Vidyasagar S; Acharya RV; Acharya V; Belle J; Shastry AB; Saravu K Malar J; 2015 Aug; 14():310. PubMed ID: 26259839 [TBL] [Abstract][Full Text] [Related]
11. Plasmodium vivax in the Era of the Shrinking P. falciparum Map. Price RN; Commons RJ; Battle KE; Thriemer K; Mendis K Trends Parasitol; 2020 Jun; 36(6):560-570. PubMed ID: 32407682 [TBL] [Abstract][Full Text] [Related]